The effect of pantoprazole and somatostatin combined with thrombin in the treatment of non-esophagogastric varicosity upper gastrointestinal bleeding
- PMID: 34150147
- PMCID: PMC8205661
The effect of pantoprazole and somatostatin combined with thrombin in the treatment of non-esophagogastric varicosity upper gastrointestinal bleeding
Abstract
Objective: To explore the effect of pantoprazole and somatostatin combined with thrombin in the treatment of non-esophagogastric varicosity upper gastrointestinal bleeding (UGB) as well as its influence on serum hs-CRP and coagulation function.
Methods: From June 2016 to May 2018, patients with upper gastrointestinal hemorrhage due to non-esophagogastric varices in our hospital were selected as research subjects. After screening, they were randomly divided into the combined group (57 cases) and the control group (57 cases). After the two groups are treated, the therapeutic effect was observed. The two groups of patients were followed up for 6 consecutive months, and the data were statistically analyzed.
Results: It was found that there wass no significant difference between the two groups in gender, age, amount of bleeding, and etiology (P > 0.05). It was found that the immediate hemostasis rate and the hemostasis rate within 24 hours in the combined group were distinctly higher compared to the control group. The difference has statistical significance (P < 0.05). The total effective rate of the combined group was distinctly higher compared to the control group (P < 0.05). By comparing the expression levels of hs-CRP and IL-6 protein in the serum of the two groups before and after treatment, it was found that there was no significant difference in the expression levels of hs-CRP and IL-6 protein before treatment. However, after treatment, it was found that the levels of hs-CRP and IL-6 protein in the combined group were distinctly lower compared to the control group (P < 0.05). By analyzing adverse reactions, it was found that the combined group had distinctly lower adverse reactions compared to the control group (P < 0.05).
Conclusion: This work provides an experimental basis for the diagnosis and treatment of non-esophagogastric varicose UGB in the clinic.
Keywords: Pantoprazole; hs-CRP; somatostatin; thrombin; upper gastrointestinal hemorrhage.
AJTR Copyright © 2021.
Conflict of interest statement
None.
Figures
Similar articles
-
Embolization combined with endoscopic variceal ligation for the treatment of esophagogastric variceal bleeding in patients with cirrhosis.Chin Med J (Engl). 2007 Jan 5;120(1):36-40. Chin Med J (Engl). 2007. PMID: 17254485 Clinical Trial.
-
Effects of Somatostatin Combined with Pantoprazole on Serum C-Reactive Protein and Intercellular Adhesion Molecule-1 in Severe Acute Pancreatitis.J Coll Physicians Surg Pak. 2019 Jul;29(7):683-684. doi: 10.29271/jcpsp.2019.07.683. J Coll Physicians Surg Pak. 2019. PMID: 31253226 Clinical Trial.
-
Curative effects of vancomycin and cefotaxime combined with gamma globulin respectively in neonatal septicemia and their influences on PCT, CRP and hs-CRP.Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4486-4494. doi: 10.26355/eurrev_202004_21031. Eur Rev Med Pharmacol Sci. 2020. PMID: 32373986
-
Spraying rhubarb powder solution under gastroscope in the treatment of acute non-varicose upper gastrointestinal bleeding: A systematic review and meta-analysis of randomized controlled trials.Complement Ther Med. 2020 Aug;52:102476. doi: 10.1016/j.ctim.2020.102476. Epub 2020 Jun 17. Complement Ther Med. 2020. PMID: 32951726
-
Treatment of nonvariceal upper gastrointestinal bleeding.Am J Health Syst Pharm. 2005 Jun 1;62(11):1159-70. doi: 10.1093/ajhp/62.11.1159. Am J Health Syst Pharm. 2005. PMID: 15914876 Review.
Cited by
-
Intravenous Drip of Somatostatin Followed by Restricted Fluid Resuscitation to Treat Upper Gastrointestinal Bleeding in Patients with Liver Cirrhosis.Evid Based Complement Alternat Med. 2021 Oct 13;2021:6548479. doi: 10.1155/2021/6548479. eCollection 2021. Evid Based Complement Alternat Med. 2021. Retraction in: Evid Based Complement Alternat Med. 2023 Jul 12;2023:9859415. doi: 10.1155/2023/9859415. PMID: 34721640 Free PMC article. Retracted.
-
Somatostatin plus Gastroscopic Administration of Omeprazole for the Treatment of Acute Upper Gastrointestinal Bleeding: An Exploration of a Promising Alternative.Evid Based Complement Alternat Med. 2022 Jul 4;2022:6329592. doi: 10.1155/2022/6329592. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Dec 13;2023:9807247. doi: 10.1155/2023/9807247. PMID: 35832530 Free PMC article. Retracted.
References
-
- Bilal M, Samuel R, Murtaza M, Khalil MK, Parupudi S, Abougergi MS. Non-variceal upper gastrointestinal hemorrhage is a rare complication after percutaneous coronary intervention for myocardial infarction, but has a detrimental effect on mortality: a national analysis over 11 months: 532. Am J Gastroenterol. 2018;113:S304.
-
- Bush DA, Hillebrand DJ, Slater JM, Slater JD. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology. 2004;127:S189–S193. - PubMed
-
- Lin TC, Chang WL. Multifocal gastrointestinal varices: a rare manifestation of immunoglobulin G4-related disease. Postgrad Med. 2019;131:176–181. - PubMed
-
- Fouad TR, Abdelsameea E, Abdel-Razek W, Attia A, Mohamed A, Metwally K, Naguib M, Waked I. Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: post-therapeutic outcome and prognostic indicators. J Gastroenterol Hepatol. 2019;34:1604–1610. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous